CardieX Overview

  • Founded
  • 1994

Founded
  • Status
  • Public

  • Employees
  • 27

Employees
  • Stock Symbol
  • CDX

Stock Symbol
  • Investments
  • 3

  • Share Price
  • $0.13

  • (As of Friday Closing)

CardieX General Information

Description

CardieX Ltd is a global health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia & Australia/New Zealand.

Contact Information

Website
www.cardiex.com
Formerly Known As
AtCor Medical
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
ASX
Primary Office
  • Suite 301, 55 Lime Street
  • Barangaroo
  • Sydney, New South Wales 2000
  • Australia
+61 (02) 0000 0000

CardieX Timeline

2020202120222023
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardieX Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.13 $0.13 $0.12 - $0.43 $18.7M 143M 157K

CardieX Financials Summary

In Thousands,
USD
TTM 31-Mar-2023 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020
EV 20,126 23,916 45,077 10,488
Revenue 2,947 2,013 2,875
EBITDA (8,548) (3,990) (1,976)
Net Income (8,558) (4,134) (2,224)
Total Assets 8,515 8,463 7,335
Total Debt 1,470 1,085 1,537
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CardieX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CardieX‘s full profile, request access.

Request a free trial

CardieX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CardieX Ltd is a global health technology company, developing solutions for health disorders. The AtCor Medical division
Diagnostic Equipment
Sydney, Australia
27 As of 2014
000.00
000000000 000.00

00000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000 000000000
Leichhardt, Australia
00 As of 0000
000.00
00.00 0000-00-00
00000000 000.00

000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000000000 000000000
Melbourne, Australia
000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CardieX Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Atomo Diagnostics Formerly VC-backed Leichhardt, Australia 00 000.00 00000000 000.00
00000000000 Corporation Melbourne, Australia 000 000.00 000000000 000.00
000000 0000000000 Corporation Melbourne, Australia 000 00.00 000000000 00.00
You’re viewing 3 of 3 competitors. Get the full list »

CardieX Patents

CardieX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210369129-A1 Wearable device with plethysmogram sensor Pending 29-May-2020 00000000000
EP-3764885-A1 System and method for cardiovascular health monitoring Inactive 15-Mar-2018 00000000000
EP-3764885-A4 System and method for cardiovascular health monitoring Inactive 15-Mar-2018 00000000000 0
US-20190282106-A1 System and method for cardiovascular health monitoring Pending 15-Mar-2018 00000000000
AU-2018252273-A1 Non-invasive blood pressure measurement Pending 13-Apr-2017 A61B5/02116
To view CardieX’s complete patent history, request access »

CardieX Executive Team (10)

Name Title Board Seat Contact Info
Craig Cooper Co-Founder & Group Chief Executive Officer
Catherine Liao Chief Strategy Officer
Ahmad Qasem Ph.D Chief Science & Research Officer
Mark Gorelick Ph.D Chief Product Officer
Michael O'Rourke Co-Founder
You’re viewing 5 of 10 executive team members. Get the full list »

CardieX Board Members (1)

Name Representing Role Since
00000 000000 Self Co-Founder & Executive Chairman 000 0000
To view CardieX’s complete board members history, request access »

CardieX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardieX Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CardieX‘s full profile, request access.

Request a free trial

CardieX Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 15-Nov-2022 0000000000 Monitoring Equipment 00000 000
00000000 0000 30-Jun-2019 0000 00000 00.000 Clinics/Outpatient Services 00000 000
Blumio 01-Nov-2018 Early Stage VC 00000 Monitoring Equipment 00000 000
To view CardieX’s complete investments and acquisitions history, request access »

CardieX Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Clinics/Outpatient Services Los Angeles, CA 0000
To view CardieX’s complete subsidiaries history, request access »